PINETREE THERAPEUTICS
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
PINETREE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Oncology Therapeutics Wellness
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.pinetreetx.com
Total Employee:
11+
Status:
Active
Total Funding:
40.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Analytics LetsEncrypt SSL By Default ReCAPTCHA Apache Cloudflare JS CDN JS
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Medicenna Therapeutics
Medicenna is a clinical stage, privately held, immuno-oncology company.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Founder
Investors List
Atinum Partners
Atinum Partners investment in Series A - PineTree Therapeutics
STIC Investment
STIC Investment investment in Series A - PineTree Therapeutics
Schmidt
Schmidt investment in Series A - PineTree Therapeutics
SGI Venture Capital
SGI Venture Capital investment in Series A - PineTree Therapeutics
S&S Investment
S&S Investment investment in Series A - PineTree Therapeutics
DSC Investment
DSC Investment investment in Series A - PineTree Therapeutics
Quantum Financing & Acquisition
Quantum Financing & Acquisition investment in Series A - PineTree Therapeutics
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Grant - PineTree Therapeutics
DSC Investment
DSC Investment investment in Series A - PineTree Therapeutics
SJ Investment Partners
SJ Investment Partners investment in Series A - PineTree Therapeutics
Official Site Inspections
http://www.pinetreetx.com
- Host name: pages-custom-29.weebly.com
- IP address: 199.34.228.77
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
More informations about "PineTree Therapeutics"
PineTree Therapeutics - Crunchbase Company Profile โฆ
AbReptor: A bi-specific and multi-specific antibody platform designed to degrade membrane-bound and extracellular proteins by co-engaging a surface-receptor or extracellular protein of interest with another proprietary receptor target.See details»
PineTree Therapeutics Inc - LinkedIn
Pinetree Therapeutics is an award-winning, pre-clinical stage biotechnology company based in Cambridge, Massachusetts. Dedicated to addressing unmet medical needs, such as drug โฆSee details»
PineTree Therapeutics - PitchBook
Www.pinetreetx.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. West Cambridge Scientific Park; 767C Concord Avenue; Cambridge, MA 02138; United StatesSee details»
Pinetree Therapeutics, Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Pinetree Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
CONTACT - PineTree Therapeutics, Inc.
Pinetree Therapeutics West Cambridge Scientific Park 767C Concord Ave Cambridge MA 02138 Website designed by Creative Eye DesignSee details»
PineTree Therapeutics - Overview, News & Similar companies
May 30, 2023 PineTree Therapeutics contact info: Phone number: (857) 654-4850 Website: www.pinetreetx.com What does PineTree Therapeutics do? PineTree Therapeutics is a pre โฆSee details»
PR 07/23/24 - PineTree Therapeutics, Inc.
Jul 23, 2024 Please visit the Companyโs website at pinetreetx.com and connect on LinkedIn for more information. Contact Clemens Reinshagen [email protected] Pinetree Therapeutics, Inc โฆSee details»
Pinetree Therapeutics, Inc - VentureRadar
Develops next-generation targeted protein degraders to combat drug resistance in oncology and other therapeutic areas. " PineTree Therapeutics Inc. is a preclinical stage Biotechnology โฆSee details»
PineTree Therapeutics, Inc. Secures $23.5 Million of Series
Jun 7, 2022 PineTree Therapeutics is a pre-clinical stage Biotech company headquartered in Cambridge, MA and was founded in 2019. It has developed the TAER-TABโข and ViTRAPโข โฆSee details»
PineTree Therapeutics, Inc. Secures $23.5 Million of โฆ
Jun 7, 2022 Investment strengthens PineTree's ability to accelerate continued growth. Cambridge, Mass., June 7, 2022 /PRNewswire/ -- PineTree Therapeutics, Inc., an emerging leader in pioneering the ...See details»
Pinetree Team - PineTree Therapeutics, Inc.
Translational Research Oncology and Virology Doctor of Medicine (Dr. med.), Georg-August-Universität Göttingen (Göttingen, Germany) and Post-Doctorate Fellowship from Harvard โฆSee details»
Pinetree Therapeutics Announces Two Appointments to โฆ
May 31, 2023 Dr. Pamela Trail joins Scientific Advisory Board Dr. John Majercak appointed as Chief Technology Officer CAMBRIDGE, Mass., May 31, 2023 /PRNewswire/ -- Pinetree โฆSee details»
Pinetree Therapeutics Announces Two Appointments to โฆ
May 31, 2023 Dr. Pamela Trail joins Scientific Advisory Board; Dr. John Majercak appointed as Chief Technology Officer; CAMBRIDGE, Mass., May 31, 2023 /PRNewswire/ -- Pinetree โฆSee details»
Pinetree Therapeutics, Inc - VentureRadar
Website: https://www.pinetreetx.com. Develops next-generation targeted protein degraders to combat drug resistance in oncology and other therapeutic areas. VentureRadar Research / โฆSee details»
Pinetree Therapeutics Announces Exclusive Option and Global โฆ
Jul 23, 2024 Please visit the Company's website at pinetreetx.com and connect on LinkedIn for more information. Contact: Clemens Reinshagen [email protected] Pinetree Therapeutics, Inc โฆSee details»
Director of Business Development - PineTree Therapeutics, Inc.
Experience working across different R&D and delivery functions within an organization to meet corporate development goals. An approach that is hands-on, results and detail oriented, and โฆSee details»
Pinetree Therapeutics, Inc. (Pinetree Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
Since its founding in 2019, Pinetreeโs platform has brought about several compelling pre-clinical programs in oncology and other therapeutic areas. Please visit the Companyโs website at โฆSee details»
Discover recipes, home ideas, style inspiration and other ideas to try.See details»
NEWS - PineTree Therapeutics, Inc.
Jun 7, 2022 Stay updated with the latest news and developments from PineTree Therapeutics, a leader in bi-specific and multi-specific antibody platforms.See details»